BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1926061)

  • 1. Antithrombin III modulates the effect of thrombin on the metabolism of glycosaminoglycans in cultured endothelial cells.
    Akai T; Kaji T; Hayakawa Y; Hayashi T; Sakuragawa N
    Thromb Res; 1991 Jun; 62(6):707-16. PubMed ID: 1926061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombin decreases glycosaminoglycans content of endothelial cells in culture.
    Kaji T; Akai T; Hayashi T; Sakuragawa N
    Thromb Res; 1991 Feb; 61(4):375-84. PubMed ID: 1905847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of lead on the glycosaminoglycans metabolism of bovine aortic endothelial cells in culture.
    Kaji T; Yamamoto C; Sakamoto M
    Toxicology; 1991; 68(3):249-57. PubMed ID: 1896998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of thrombin on the production of glycosaminoglycans by cultured endothelial cells.
    Kaji T; Akai T; Hayashi T; Sakuragawa N
    Thromb Res; 1991 Jun; 62(5):509-17. PubMed ID: 1896966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of heparan sulphate release from cultured endothelial cells by plasmin.
    Kaji T; Sakamoto M
    Blood Coagul Fibrinolysis; 1991 Jun; 2(3):419-23. PubMed ID: 1834236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin cofactor II inhibits thrombin-stimulated release of tissue plasminogen activator from cultured human endothelial cells in the presence of dermatan sulfate.
    Kaji T; Ejiri N; Hayakawa Y; Hayashi T; Sakuragawa N
    Thromb Res; 1990 Jul; 59(2):269-77. PubMed ID: 2122537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of glycosaminoglycan production and antithrombin III binding by cultured aortic endothelial cells treated with 4-methylumbelliferyl-beta-D-xyloside.
    Shimada K; Ozawa T
    Arteriosclerosis; 1987; 7(6):627-36. PubMed ID: 3689206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between cadmium and zinc in the production and sulfation of glycosaminoglycans in cultured bovine vascular endothelial cells.
    Ohkawara S; Kaji T; Yamamoto C; Fujiwara Y; Sakamoto M; Kozuka H
    J Toxicol Environ Health; 1996 Feb; 47(2):183-93. PubMed ID: 8598574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutralization of thrombin by antithrombin III in the presence of cultured human fibroblasts.
    Brandt JT; Stephens RE; Hinkle GH
    Thromb Res; 1988 Jul; 51(2):187-96. PubMed ID: 2973155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different glycoforms of human thrombomodulin. Their glycosaminoglycan-dependent modulatory effects on thrombin inactivation by heparin cofactor II and antithrombin III.
    Koyama T; Parkinson JF; Sié P; Bang NU; Müller-Berghaus G; Preissner KT
    Eur J Biochem; 1991 Jun; 198(3):563-70. PubMed ID: 1646716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulant heparin-like glycosaminoglycans on endothelial cell surface.
    Shimada K; Kobayashi M; Kimura S; Nishinaga M; Takeuchi K; Ozawa T
    Jpn Circ J; 1991 Oct; 55(10):1016-21. PubMed ID: 1744977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phorbol 12-myristate 13-acetate stimulates the release of glycosaminoglycans from cultured vascular endothelial cells: possible involvement of protein kinase C activation.
    Fujii N; Kaji T; Yamamoto C; Fujiwara Y; Koizumi F
    Thromb Res; 1996 Jun; 82(5):379-87. PubMed ID: 8771698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of thrombin with heparin cofactor II and antithrombin III on prostacyclin production by cultured endothelial cells.
    Kaji T; Itoh F; Hayakawa Y; Oguma Y; Sakuragawa N
    Thromb Res; 1989 Oct; 56(1):99-107. PubMed ID: 2512688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin cofactor II is degraded by heparan sulfate and dextran sulfate.
    Saito A
    Biochem Biophys Res Commun; 2015 Feb; 457(4):585-8. PubMed ID: 25600805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of thrombin by antithrombin III and heparin cofactor II in vivo.
    Liu L; Dewar L; Song Y; Kulczycky M; Blajchman MA; Fenton JW; Andrew M; Delorme M; Ginsberg J; Preissner KT
    Thromb Haemost; 1995 Mar; 73(3):405-12. PubMed ID: 7545318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of glycosaminoglycans and antithrombin III on uptake and inhibition of thrombin by the vascular wall.
    Dryjski M; Larsson R; Olsson P; Swedenborg J
    Thromb Res; 1983 Nov; 32(4):355-63. PubMed ID: 6658719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The antithrombin action of stichopus japonicus acid mucopolysaccharide (Sjamp) is mediated by heparin cofactor II].
    Zhang G
    Zhonghua Xue Ye Xue Za Zhi; 1997 Mar; 18(3):126-9. PubMed ID: 15622771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutagenesis of thrombin selectively modulates inhibition by serpins heparin cofactor II and antithrombin III. Interaction with the anion-binding exosite determines heparin cofactor II specificity.
    Sheehan JP; Wu Q; Tollefsen DM; Sadler JE
    J Biol Chem; 1993 Feb; 268(5):3639-45. PubMed ID: 8429040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms for the anticoagulant effect of heparin and related polysaccharides.
    Ofosu FA
    Nouv Rev Fr Hematol (1978); 1988; 30(3):155-60. PubMed ID: 2971155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effect of heparin cofactor II on thrombin-stimulated prostacyclin production by cultured vascular smooth muscle cells.
    Hayashi T; Kaji T; Hayakawa Y; Niiya K; Sakamoto M; Sakuragawa N
    Thromb Res; 1991 Nov; 64(3):321-30. PubMed ID: 1805447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.